Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

UCB Pharma Limited
208 Bath Road, Slough, Berkshire, SL1 3WE
Telephone: +44 (0)1753 534 655
Medical Information Direct Line: +44 (0)1753 447 690
Medical Information e-mail: Medicalinformationuk@ucb.com
Customer Care direct line: +44 (0) 1773 510123

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 17/07/2008
SPC Isoket Retard 20

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/07/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
  • Company name change or merger
  • Change of Marketing Authorisation Holder
Date of revision of text on the SPC:   30-Jun-2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Updated to reflect change of ownership from Schwarz Pharma Ltd to UCB Pharma Ltd.
Updated on 19/09/2007 and displayed until 17/07/2008
Reasons for adding or updating:
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   09/2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 9: the date has changed to 07 September 2007
 
Section 10: the date has changed to September 2007
Updated on 27/09/2006 and displayed until 19/09/2007
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Date of revision of text on the SPC:   07/2006
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 7 (MA Holder) - New address added: SCHWARZ PHARMA Limited, 5 Hercules Way, Leavesden Park, Watford, WD25 7GS, United Kingdom.
 
Section 10 (Date of revision of text) - New date added: July 2006
Updated on 10/06/2005 and displayed until 27/09/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 02/06/2005 and displayed until 10/06/2005
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 3 - pharmaceutical form
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.3 - Contra-indications
Updated on 31/07/2002 and displayed until 02/06/2005
Reasons for adding or updating:
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 13/08/2001 and displayed until 31/07/2002
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 09/08/2001 and displayed until 13/08/2001
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 09/10/2000 and displayed until 09/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 26/01/2000 and displayed until 09/10/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  isosorbide dinitrate